LAWSUITS NEWS & LEGAL INFORMATION
Bayer Corporation
Tallahassee, FL: Florida Attorney General Bill McCollum announced that Florida and 29 additional states have reached an $8 million settlement with Bayer Corporation, resolving an investigation into the marketing of a drug to lower cholesterol. The settlement was part of a consumer protection enforcement action initiated over concerns that Bayer failed to adequately disclose safety risks associated with Baycol.
Baycol is a type of cholesterol-lowering drug known as a statin. Statins carry a known risk of myopathy, a weakening of the muscles, as well as a more serious muscular disease. Baycol was withdrawn from the prescription drug market in August 2001 on post marketing studies showed up potential health hazards particularly in combination with another cholesterol-lowering drug. The investigation, initiated by the states in 2004, alleged that while Bayer informed the US Food and Drug Administration about these adverse effects, the company failed to adequately warn consumers. (Jan-24-07) [ALL AMERICAN PATRIOTS: BAYER BAYCOL]
Baycol is a type of cholesterol-lowering drug known as a statin. Statins carry a known risk of myopathy, a weakening of the muscles, as well as a more serious muscular disease. Baycol was withdrawn from the prescription drug market in August 2001 on post marketing studies showed up potential health hazards particularly in combination with another cholesterol-lowering drug. The investigation, initiated by the states in 2004, alleged that while Bayer informed the US Food and Drug Administration about these adverse effects, the company failed to adequately warn consumers. (Jan-24-07) [
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.Published on Jan-25-07
